Exane Derivatives’s MALLINCKRODT PUBLIC LIMITED COMPANY MNK Stock Holding History

Exane Derivatives’s Portfolio MNK Stock Details MNK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1	Closed	-$29	–	756
2018 Q3	$29	Hold	1	–	–	﹤0.01%	661
2018 Q2	$19	Hold	1	–	–	﹤0.01%	670
2018 Q1	$14	Sell	1 -156	-99%	-$2.81K	﹤0.01%	616
2017 Q4	$3.54K	Sell	157 -357	-69%	-$9.57K	﹤0.01%	440
2017 Q3	$19.2K	Buy	514 +501	+3,854%	+$19.9K	﹤0.01%	358
2017 Q2	$582	Sell	13 -237	-95%	-$10.4K	﹤0.01%	496
2017 Q1	$11.1K	Buy	250 +90	+56%	+$4.44K	﹤0.01%	347
2016 Q4	$7.97K	Hold	160	–	–	﹤0.01%	417
2016 Q3	$11.2K	Sell	160 -1,290	-89%	-$93.3K	﹤0.01%	391
2016 Q2	$88.1K	Buy	1,450 +1,400	+2,800%	+$85.6K	0.01%	245
2016 Q1	$3.06K	Buy	+50	New	+$3.2K	﹤0.01%	450

Other funds holding MNK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Exane Derivatives's MNK Position: Q4 2018 in Review

Exane Derivatives sold out of MALLINCKRODT PUBLIC LIMITED COMPANY (MNK) in Q4 2018, closing a stake of 1 share — an estimated $29 sold.

Exane Derivatives first reported a position in MNK in Q1 2016 and held it in 11 quarters. The position peaked at $88.1K in Q2 2016. 323 funds tracked by Wall St. Rank hold MNK as of Q4 2018.

Exane Derivatives reported no remaining MALLINCKRODT PUBLIC LIMITED COMPANY position as of Q4 2018 after selling out during the quarter.
Exane Derivatives sold 1 MALLINCKRODT PUBLIC LIMITED COMPANY share in Q4 2018, an estimated $29.
Exane Derivatives first reported a position in MALLINCKRODT PUBLIC LIMITED COMPANY in Q1 2016 and held it in 11 quarters.
Exane Derivatives's MALLINCKRODT PUBLIC LIMITED COMPANY position peaked at $88.1K in Q2 2016.
323 funds tracked by Wall St. Rank held MALLINCKRODT PUBLIC LIMITED COMPANY as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.